NSLHD News - 14 February 2025

NSLHD Intellectual Property Committee

NSLHD boosts intellectual property expertise As the district strengthens its clinical trial expertise and capacity, it has appointed a new Intellectual Property and Commercialisation Committee. A diverse group of members have joined

trademarks and copyrights. “Importantly, this committee will help NSLHD safeguard its intellectual property and leverage it effectively,” she said. “The expert committee will help align our IP management with our broader strategic direction and ensure our IP assets are protected. “This will be an important step towards supporting our researchers’ innovative ideas, the growth of the district’s research portfolio, and reputation as a leader in research. “As the district expands its research and clinical trial expertise, it’s crucial we have a robust approach to intellectual property and commercialisation. “This new committee will assist us as we expand our culture of embedding clinical trials as therapy into everything that we do.”

the committee including the Head of Intellectual Property at Corrs Chambers Westgarth Eugenia Kolivos, former Head of Commercialisation at CSIRO Laurence Street, and Dr Stephanie Allen, a senior partner at Kearney with a depth of experience in commercialisation, IP and organisational strategy. The independent members will be joined by NSLHD Chief Executive Anthony Schembri, Executive Director Research Associate Professor Naomi Hammond, Executive Director of Finance, Jacqueline Ferguson, Manager Research Strategy and Partnerships Dr Rebeka Freckleton and Director of Legal Natasha Patney. Naomi said the new committee will provide a crucial role, overseeing the management, protection and enforcement of NSLHD’s intellectual property rights, including patents,

NSLHDNEWS | ISSUE 2| 14 FEBRUARY 2025

10

Made with FlippingBook - professional solution for displaying marketing and sales documents online